Physician profile
Dilantha Ellegala
NPI 1710056080
$16,108.43
in general payments reported to CMS, 2019-2025
8 companies · $350 in 2025
The $350 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.18 · 2020: $23.60 · 2021: $14K · 2022: $839 · 2024: $498 · 2025: $350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $498 · Travel and Lodging: $294 · Consulting Fee: $55.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $498.02 |
| Travel and Lodging | $294.11 |
| Consulting Fee | $55.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Misonix INC | $14,333.87 | 2020-2021 | |
| Bioventus LLC | $839.00 | 2022 | |
| Centinel Spine, LLC | $629.78 | 2024-2025 | Prodisc L, Prodisc C Vivo |
| Abbott Laboratories | $141.65 | 2024 | Proclaim |
| Spineology INC. | $75.75 | 2019-2021 | |
| Xtant Medical INC | $44.86 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $31.33 | 2024 | |
| Surgalign Spine Technologies, INC. | $12.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dilantha Ellegala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.